Day: October 6, 2014

Update #1: Study Suggests Higher Inhibitor Incidence in PUPS Using Kogenate/Helixate

The medical journal, Blood, came out with a study called, Recombinant Factor VIII Products and Inhibitor Development in Previously Untreated Boys with Severe Hemophilia A.  This study suggests that inhibitor incidence is higher in previously untreated patients (PUPs) with severe Hemophilia A that are using Kogenate/Helixate (Bayer/Nexgen).Click here to read the abstract of this study.*Note: Unfortunately, […]